衰老和传染病在肌痛性骨髓灰质炎
1Division of Neurology, Department of Medicine, University Health Network, University of Toronto, Toronto, Ontario, Canada.
Journal of the neurological sciences
|December 13, 2024
概括
肌痛性骨髓灰质炎 (MG) 的死亡率有所下降,但其发病率和患病率正在上升,特别是在老年人中. 在MG患者中感染风险增加需要警监测和治疗.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
- 流行病学 流行病学
背景情况:
- 在过去的120年中,肌痛性骨髓灰质炎 (MG) 的死亡率有所下降,但发病率和流行率正在增加.
- 脑膜炎患病率的增加与诊断的进步,人口老龄化和免疫衰老有关,在65岁及以上的人群中观察到显著增加.
- 一种独特的"非常晚发"的MG亚型 (≥65岁) 具有抗乙胆受体 (AChR) 抗体和缺少胸腺瘤的特征.
研究的目的:
- 分析过去120年来肌痛性骨髓灰质炎 (MG) 发病率,流行率和死亡率的趋势.
- 研究人口老龄化和免疫性对MG患病率和表现的影响.
- 突出MG患者对感染的敏感性增加以及对管理的影响.
主要方法:
- 对120年的流行病学数据进行了回顾性分析.
- 骨髓灰质炎 (MG) 患者的死亡率和发病率与一般人群的比较.
- 对不同年龄组的临床特征和治疗考虑的审查,包括晚发性MG.
主要成果:
- 骨髓灰质炎 (MG) 的死亡率已经下降到5%以下,但患病率已经上升,特别是在老年人 (≥65岁).
- 非常晚发的MG (≥65岁) 通常是抗AChR抗体阳性和胸腺瘤阴性,具有明显的治疗考虑.
- 由于免疫和免疫抑制疗法,MG患者面临更高的感染风险,导致整体死亡率更高.
结论:
- 尽管治疗方法有所改善,但肌痛性骨髓灰质炎 (MG) 患者的死亡率较高,主要是由于感染相关的并发症和恶化.
- 在监测和治疗感染方面提高警对于管理严重肌痛性肌痛症 (MG) 和降低相关死亡率至关重要.
- 与年龄相关的变化,包括免疫衰变,在肌痛性骨髓灰质炎 (MG) 病因,表现和感染易感性方面发挥着重要作用.
更多相关视频
12:18The Neuromuscular Junction: Measuring Synapse Size, Fragmentation and Changes in Synaptic Protein Density Using Confocal Fluorescence Microscopy
Published on: December 26, 2014
21.6K
04:30Author Spotlight: Translational Applications of Stimulated SFEMG in Rodent Models
Published on: March 8, 2024
601
相关概念视频
01:20Myasthenia Gravis: Overview and Treatment
1.2K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.2K
01:15Myasthenia Gravis: Diagnostic Tests
644
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
644
01:28Disorders of the Skeletal Muscle
876
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
876
01:26Chemical Synapses
8.7K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
8.7K
01:30Indirect-Acting Cholinergic Agonists: Pharmacological Actions
618
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
618
01:10Muscle Contraction
6.2K
In skeletal muscles, acetylcholine is released by nerve terminals at the motor endplate—the point of synaptic communication between motor neurons and muscle fibers. The binding of acetylcholine to its receptors on the sarcolemma allows entry of sodium ions into the cell and triggers an action potential in the muscle cell. Thus, electrical signals from the brain are transmitted to the muscle. Subsequently, the enzyme acetylcholinesterase breaks down acetylcholine to prevent excessive...
6.2K